5417-83-4

Usage

Molecular Structure

1-methyl-6-(methylsulfanyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one has a complex molecular structure that includes a pyrazolo[3,4-d]pyrimidin-4-one ring system, a methylsulfanyl substituent at the 6-position, and a methyl group at the 1-position.

Ring System

The compound contains a pyrazolo[3,4-d]pyrimidin-4-one ring system, which is a fusion of a pyrazole and a pyrimidine ring.

Methyl Group

A methyl group is attached to the 1-position of the molecule, contributing to its structure and properties.

Methylsulfanyl Substituent

A methylsulfanyl group is attached to the 6-position of the molecule, adding sulfur to the structure and potentially influencing its reactivity and interactions with other molecules.

Potential Pharmaceutical Applications

Due to its unique structure, 1-methyl-6-(methylsulfanyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one may have potential pharmaceutical or biological applications.

Building Block for Synthesis

The compound could be used as a building block in the synthesis of other compounds, allowing for the creation of new molecules with various properties and applications.

Starting Point for Drug Development

As a unique chemical structure, it could serve as a starting point for the development of new drugs, potentially leading to the discovery of novel therapeutic agents.

Need for Further Research

To fully understand the properties and potential uses of 1-methyl-6-(methylsulfanyl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, further research and studies are needed. This includes exploring its chemical reactivity, stability, and interactions with other molecules, as well as its potential biological activity and therapeutic applications.

Upstream product

• 5334-27-0 1-methyl-6-thioxo-1,5,6,7-tetrahydro-pyrazolo[3,4-d]pyrimidin-4-one 
• 77-78-1 dimethyl sulfate 
• 18213-75-7 5-amino-1-methyl-1H-pyrazole-4-carboxylic acid amide 
• 70011-76-6 1-methyl-4,6-dimethylthiopyrazolo[3,4-d]pyrimidine 
• 74-88-4 methyl iodide 
• 31037-02-2 ethyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate 
• 5334-27-0 1-methyl-6-sulfanyl-5H-pyrazolo[3,4-d]pyrimidin-4-one 
• 5334-35-0 6-chloro-1-methyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one 

Downstream Products

• 223464-75-3 5-benzyl-1-methyl-6-methylsulfanyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one 
• 223464-86-6 5-benzyl-1-methyl-1,7-dihydro-pyrazolo[3,4-d]pyrimidine-4,6-dione 
• 223464-77-5 5-benzyl-6-methanesulfonyl-1-methyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one 
• 1616414-42-6 (3S)-4-[6-(2-hydroxyethylamino)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 

Relevant academic research and scientific papers

BICYCLIC HETEROCYCLIC COMPOUNDS AS INHIBITORS OFBCDIN3D ACTIVITY

The present invention relates to compounds that function as inhibitors and/or degraders of BCDIN3D activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to the

THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES

A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4- position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseasesand malaria; and organ and cell transplant rejection.